1. Andre T, Louvet C, Artru P, Selle F, Turnigand C, Garcia ML, Avenin D, Maindrault F, Provent S, DeGramont A (2001) A phase II study of gemcitabine and oxaliplatin (GEMOX) in advanced biliary adenocarcinoma (ABA). Preliminary results. Eur J Cancer 37, (Suppl 6) 19
2. Arroyo G, Gallardo J, Rubio B, Orlandi L, Yañez M, Gamargo C, Ahumada M, Zarba J, Berlingeri G, Kowalyszyn R (2001) Gemcitabine (GEM) in advanced biliary tract cancer (ABTC). Experience from Chile and Argentina in phase II trials. Proc Am Soc Clin Oncol 20: A626 (abstract)
3. Carraro S, Servienio PJ, Bruno MF, Castillo Odena MDS, Roca E, Jovtis S, Felci N, Araujo C (2001) Gemcitabine and cisplatin in locally advanced or metastatic gallbladder and bile duct adenocarcinomas. Proc Am Soc Clin Oncol 20: A2333 (abstract)
4. De Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341: 1368–1378
5. Dobrila R, Kovac D, Depolo A, Dintinjana M (2000) Gemcitabine in patients with nonresectable cancer of the biliary system or advanced gallbladder cancer. Am J Gastroenterol 95: 2476 (abstract)